Global Doppler Ultrasound Systems Market Size

Doppler Ultrasound Systems Market Analysis

The doppler ultrasound systems market is expected to register a CAGR of 7.5% over the forecast period.

The outbreak of the pandemic impacted the doppler ultrasound market. A high rate of thrombotic events was associated with the COVID-19 infection, such as deep vein thrombosis (DVT) and acute pulmonary embolism, which propelled the use of doppler ultrasound during the pandemic. For instance, as per a July 2021 NCBI article, during the pandemic, an increased incidence of asymptomatic DVT (60.87%) was noted. It also mentioned that color doppler ultrasound allowed detection of DVT in asymptomatic patients, but venous doppler ultrasound was accepted as a critical intervention for COVID-19 patients at risk of thrombotic complications, which helped physicians to make decisions. Thus, the market witnessed positive growth during the pandemic and is expected to continue the upward trend over the forecast period.

The rising prevalence of chronic diseases coupled with the aging population, growing healthcare spending in developed nations, an increase in healthcare providers, and healthcare spending on diagnosis are the major drivers for the market. The development of advanced doppler ultrasound diagnostic technologies is another important element fueling market growth. Chronic diseases like cancer, and cardiovascular, gastrointestinal, and kidney ailments are becoming more prevalent throughout the world. For instance, in 2022, the American Cancer Society (ACS) that there would be an estimated 106,180 new cases of colon cancer and 44,850 new cases of rectal cancer in the United States in 2023. Furthermore, according to a 2021 report by the American Cancer Society, the lifetime risk of developing colorectal cancer was about 1 in 23 (4.3%) for men and 1 in 25 (4.0%) for women. Doppler ultrasound is one of the essential requirements for the diagnosis of cancer and this steady increase in the number of cases will propel the demand for doppler ultrasound systems.

In addition, numerous studies are being conducted to determine the diagnostic use of the doppler ultrasound in various disorders. For instance, a team of researchers from Dalian Medical University in China began a study in July 2021 to investigate the diagnostic use of doppler ultrasound in patients with early chronic renal disease. Furthermore, in April 2022, a different team of researchers from the University of British Columbia in Vancouver, Canada, published a research study that states that doppler imaging is frequently used to evaluate transplanted kidneys and is utilized to evaluate renal vascular flow and patency.

The market participants are also concentrating on doppler ultrasound systems and driving market expansion. For instance, in January 2021, EagleView ultrasound launched its wireless portable ultrasound device, which provides accurate ultrasound imaging and is affordable as well. Similarly, Us2.ai, a Singapore-based medtech company supported by Sequoia India and EDBI, gained FDA approval for Us2.v1, a fully automated cardiac ultrasound tool to measure 2D and doppler, in September 2021. It is projected that during the course of the projection period, advances in the doppler ultrasound system will spur market expansion.

However, stringent regulatory policies and the excessive cost of doppler ultrasound systems are expected to hamper the market growth over the forecast period.